EMPA 10 mg contains Empagliflozin 10 mg. It is an oral antidiabetic medicine belonging to the SGLT2 inhibitor class, used to lower blood glucose levels in patients with type 2 diabetes by increasing glucose removal through urine.
Uses:
Management of type 2 diabetes mellitus
Helps improve blood sugar control along with diet and exercise
Reduces the risk of cardiovascular complications in appropriate patients with type 2 diabetes
Helps reduce the risk of hospitalization due to heart failure in certain patients
May provide kidney protection in some patients with chronic kidney disease associated with diabetes (as prescribed)
Dose:
Adults: Usually 10 mg once daily, or as directed by a physician
May be increased to 25 mg once daily if additional blood sugar control is needed and tolerated
Can be taken with or without food
Maintain adequate fluid intake unless restricted by a doctor
Do not stop or change the dose without medical advice